VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
ERIE
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
ERIEErie Indemnity Company
$259.25$12.0B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksERIEQuarterly Financials

Erie Indemnity Company (ERIE) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Erie Indemnity Company (ERIE) quarterly income statement — complete revenue, gross profit & net income history

ERIE Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Revenue1.01B951.2M1.3B1.06B989.4M924.09M999.89M990.44M880.7M817.67M858.94M839.87M752.47M700.63M741.24M726.14M672.11M635.93M687.84M680.03M
Revenue Growth %2.28%2.93%30.42%7.03%12.34%13.02%16.41%17.93%17.04%16.7%15.88%15.66%11.96%10.17%7.76%6.78%6.65%4.38%5.26%3.5%
Medical Costs & Claims0812.46M857.82M860.92M838.02M756.78M819.76M800.23M741.89M690.58M710.47M705.71M641.92M619.21M634.76M622.14M587.8M574.1M592.74M594.97M
Medical Cost Ratio %0%85.41%65.78%81.21%84.7%81.89%81.99%80.8%84.24%84.46%82.71%84.03%85.31%88.38%85.64%85.68%87.46%90.28%86.17%87.49%
Gross Profit0138.74M446.26M199.17M151.38M167.31M180.13M190.21M138.81M127.08M148.47M134.16M110.54M81.43M106.47M104M84.31M61.83M95.1M85.06M
Gross Margin %0%14.59%34.22%18.79%15.3%18.11%18.01%19.2%15.76%15.54%17.29%15.97%14.69%11.62%14.36%14.32%12.54%9.72%13.83%12.51%
Gross Profit Growth %-100%-17.08%147.75%4.71%9.05%31.65%21.32%41.78%25.57%56.07%39.45%29%31.11%31.69%11.95%22.26%10.8%-4.95%-1.17%-6.72%
Operating Expenses845.12M-19M236.01M00000000000000000
OpEx / Revenue %83.52%-2%18.1%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%
Depreciation & Amortization019.15M18.4M14.13M14.13M14.13M11.85M11.85M11.85M11.85M11.54M11.54M11.54M11.54M9.3M9.3M9.3M9.3M5.3M5.3M
Combined Ratio %83.52%83.42%83.88%81.21%84.7%81.89%81.99%80.8%84.24%84.46%82.71%84.03%85.31%88.38%85.64%85.68%87.46%90.28%86.17%87.49%
Operating Income166.79M157.74M210.25M199.17M151.38M167.31M180.13M190.21M138.81M127.08M148.47M134.16M110.54M81.43M106.47M104M84.31M61.83M95.1M85.06M
Operating Margin %16.48%16.58%16.12%18.79%15.3%18.11%18.01%19.2%15.76%15.54%17.29%15.97%14.69%11.62%14.36%14.32%12.54%9.72%13.83%12.51%
Operating Income Growth %10.18%-5.72%16.73%4.71%9.05%31.65%21.32%41.78%25.57%56.07%39.45%29%31.11%31.69%11.95%22.26%10.8%-4.95%-1.17%-6.72%
EBITDA166.79M176.89M228.65M213.31M165.51M181.44M191.98M202.06M150.67M138.94M160.01M145.7M122.08M92.97M115.77M113.3M93.61M71.14M100.4M90.36M
EBITDA Margin %16.48%18.6%17.53%20.12%16.73%19.63%19.2%20.4%17.11%16.99%18.63%17.35%16.22%13.27%15.62%15.6%13.93%11.19%14.6%13.29%
Interest Expense00000000000000115K895K999K1.05M1.03M1.04M
Non-Operating Income075.39M0-5.63M-6.1M-15.15M-4.9M-9.4M-8.66M-8.14M-8.14M-8.14M-8.14M-1.51M-1.51M-1.51M-1.51M1.02M1.02M1.02M
Pretax Income190.33M82.35M232.76M220.75M174.75M191.81M200.84M207.33M157.3M139.92M163.77M149.09M109.15M81.96M106.35M101.35M86.8M69.83M114.13M99.9M
Pretax Margin %18.81%8.66%17.85%20.82%17.66%20.76%20.09%20.93%17.86%17.11%19.07%17.75%14.51%11.7%14.35%13.96%12.91%10.98%16.59%14.69%
Income Tax39.85M18.97M49.91M46.06M36.33M39.78M41.01M43.42M32.75M29M32.73M31.24M22.91M16.47M22.04M21.2M18.18M14.79M23.9M20.87M
Effective Tax Rate %20.94%23.03%21.44%20.87%20.79%20.74%20.42%20.94%20.82%20.72%19.99%20.95%20.99%20.1%20.72%20.92%20.94%21.17%20.94%20.89%
Net Income150.47M63.38M182.85M174.69M138.42M152.03M159.83M163.9M124.55M110.93M131.04M117.85M86.24M65.49M84.31M80.15M68.62M55.04M90.22M79.03M
Net Margin %14.87%6.66%14.02%16.48%13.99%16.45%15.98%16.55%14.14%13.57%15.26%14.03%11.46%9.35%11.37%11.04%10.21%8.66%13.12%11.62%
Net Income Growth %8.71%-58.31%14.4%6.58%11.13%37.05%21.97%39.08%44.42%69.38%55.42%47.04%25.68%18.98%-6.55%1.41%-6.72%-12.33%1.13%-3.6%
EPS (Diluted)2.861.203.473.342.652.913.063.132.382.112.512.251.651.241.611.531.311.051.721.51
EPS Growth %7.92%-58.76%13.4%6.71%11.34%37.91%21.91%39.11%44.24%70.16%55.9%47.06%25.95%18.1%-6.4%1.32%-7.09%-12.5%0.58%-3.82%
EPS (Basic)3.231.363.933.752.973.263.433.522.672.382.812.531.851.411.811.371.171.181.941.70
Diluted Shares Outstanding52.69M52.69M52.69M52.31M58.41M52.31M52.31M52.69M52.68M52.68M52.68M52.68M58.4M52.68M52.3M58.4M58.4M52.31M52.31M58.4M